戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 1 day is usually more than 50% of the 6-week blood flow rate.
2  PAOM measured the sO2 and SD-OCT mapped the blood flow rate.
3  isoform expression did not affect growth or blood flow rate.
4 rements included minimum venous diameter and blood flow rate.
5 onstant velocity despite large variations in blood flow rate.
6 ficantly decreased vessel diameter and local blood flow rate.
7  into the mice, which is consistent with the blood-flow rate.
8 t aggregation in SCD mice, thereby improving blood flow rates.
9 endocardial perfusion across a wide range of blood flow rates (0 to >5.0 mL/min/g).
10 er absolute 10% difference in FMD: change in blood flow rate =11.6%; 95% CI, 0.6% to 23.9%; P=0.04; c
11 er absolute 10% difference in NMD: change in blood flow rate =14.0%; 95% confidence interval [95% CI]
12 tients were randomized to receive one of two blood flow rates: 150 or 250 mL/min.
13 tely increased portal-drained visceral (PDV) blood flow rate (+25%) and intestinal blood volume (+51%
14 sis machine; Fresenius F80B dialyzer; median blood flow rate 400 ml/min; dialysate flow rate 600 ml/m
15 one filter (1.2 m2; mean pore size, 0.50 nm; blood flow rate, 400 mL/min; ultrafiltrate, "zero-balanc
16  = 0.01), and a significantly reduced venous blood flow rate (9.7 +/- 3.1 microL/min) compared with t
17                                   Rationale: Blood flow rate affects mixed venous oxygenation (Sv(O(2
18 ere was no significant change in the retinal blood flow rate after treatment.
19                                   We studied blood flow rates along the sciatic nerve and in the supe
20 eater NMD associated with greater 6-week AVF blood flow rate and AVF diameter (per absolute 10% diffe
21 ociated with greater increases in 6-week AVF blood flow rate and AVF diameter (per absolute 10% diffe
22                                              Blood flow rate and CO2 removal in these trials were 2.1
23 ive Day 1, Week 2, and Week 6 to measure AVF blood flow rate and diameter of the draining vein and pr
24 tively associated with changes in 6-week AVF blood flow rate and diameter, suggesting that native fun
25 nt relationships with both postoperative AVF blood flow rate and diameter.
26 d concentration in portal vein blood, portal blood flow rate and glucagon concentration, with methion
27 2 is challenging because two parameters, the blood flow rate and hemoglobin oxygen saturation (sO2),
28 rticle assesses the hypothesis that the high blood flow rate and low O(2) extraction associated with
29 ng functional information from scans such as blood flow rate and oxygen consumption provides new pers
30                                     Targeted blood flow rate and support duration were 2-2.5 L/min an
31 rative VFT to ultrasound measurements of AVF blood flow rate and venous diameter at 1 day, 2 weeks, a
32                                              Blood flow rates and pulsatility indexes from 13 major a
33  left ventricular pressure, aortic pressure, blood flow rate, and aortic orifice area are examined.
34               Angiogenesis, vessel diameter, blood flow rate, and vascular permeability were proporti
35 e effects of varying the degree of stenosis, blood flow rate, and viscosity on two diagnostic metrics
36     Changes in carotid and mesenteric artery blood flow rates, as a percent of baseline values, showe
37                                          AVF blood flow rate at 1 day is usually more than 50% of the
38 an be used effectively to compare myocardial blood-flow rates at rest and stress levels.
39 se, and increasing platelet dysfunction with blood flow rate (BFR) and Vintage.
40                         Changes in pulmonary blood flow rate can alter the size of the perfused pulmo
41                      Change in portal venous blood flow rates did not have an effect on the size and
42 directionally from the SCN to the OVLT, that blood flow rate displays daily oscillations with a highe
43 (r = 0.95, P <.001) across the full range of blood flow rates encountered (from 0 to >5.0 mL/min/g).
44  record for reductions in prescribed time or blood flow rates followed by vascular access testing.
45 ximetry), end-tidal PCO2, and carotid artery blood flow rate, for which data were collected at 15-min
46 on of blood-borne therapeutic agents and low blood flow rate in tumors.
47       These adaptations resulted in hindlimb blood flow rates in IUGR that were similar to control fe
48         Noted for having some of the highest blood flow rates in the body, the choroidal vasculature
49 gnificantly higher cardiac outputs and renal blood flow rates in treated animals compared with sham c
50 rast, in skeletal muscle and left ventricle, blood flow rates increased in the albumin-transfused gro
51                         To determine whether blood flow rate influences circuit life in continuous re
52 oral nutrient foramina show Morganucodon had blood flow rates intermediate between living mammals and
53 cid and p-cresyl glucuronide, an increase in blood flow rate is advantageous.
54                     We conclude that retinal blood flow rate is reduced significantly in the diabetic
55 n 23 consecutive patients with an inadequate blood flow rate (&lt; 200 mL/min) during hemodialysis.
56 tressed neonates with extremely low cerebral blood flow rates may have relatively normal short-term n
57 ior to 6 weeks, at least 50% of their 6-week blood flow rate measurement was achieved at 1 day.
58 ol circuit or NO test circuit for 4 hrs at a blood flow rate of 109-118 mL/min via roller pump.
59  bilirubin in allo-hemodialysis with neonate blood flow rates of 12.5 and 15 mL/min (for a 2.5 kg and
60  no difference in circuit life whether using blood flow rates of 250 or 150 mL/min during continuous
61  2 microglobulin clearances were measured at blood flow rates of 300 ml/min (Qb 300) and 400 ml/min (
62 LP-2 plus L-NAME did not increase either PDV blood flow rate or glucose uptake.
63 did not differ in body size, treatment time, blood flow rate, or net fluid removal.
64        Each compartment was characterized by blood flow rate, organ volume and lymphatic flow rate, a
65 hat is required to reestablish baseline MAP, blood flow rates, oxygen delivery, PrCO2, and pHi.
66 l (r2 = .48; P < .0001) but not with in vivo blood flow rate (P = .45).
67 bolytic locks have been shown to improve CVC blood flow rates, prevent infection, and reduce dysfunct
68 mulations were generated for eight different blood-flow rates reflecting the physiological range of i
69 espiratory distress syndrome, increased ECMO blood flow rate resulting in higher Sv(O(2)) decreases p
70   Continuous renal replacement therapy using blood flow rate set at 250 mL/min was not more likely to
71 rapid H(+) and lactate efflux resulting from blood flow rates that are among the highest reported for
72    Performance parameters evaluated included blood flow rates, urea reduction percentages, and recirc
73                                  The average blood flow rate was 281.4 mL/min (range, 117.1-405.6 mL/
74                                      Retinal blood flow rate was found to decrease by approximately 3
75 jection of streptozotocin (STZ), and retinal blood flow rate was measured under anesthesia by a micro
76 ry normalized after transplantation, and the blood flow rate was reduced in all patients who underwen
77                                          The blood flow rate was then returned to 100 mL/kg/min.
78               AVF draining vein diameter and blood flow rate were assessed postoperatively after 1 da
79   Blood column diameter, blood velocity, and blood flow rate were measured in the major superior temp
80                   Mean fistula diameters and blood flow rates were compared by using analysis of vari
81 rotid, superior mesenteric, and renal artery blood flow rates were measured at normocapnic baseline a
82  of 14 infants, both early and late cerebral blood flow rates were measured.
83          Right and left hemispheric cerebral blood flow rates were significantly correlated with each
84 omplications, especially when applied at low blood-flow rates with devices designed for higher blood